Trump to announce discount drug pricing expansion, White House official says
Could pressure to make money faster kill the next lifesaving pill?
Pharma ETF (FTXH) Hits New 52-Week High
Trump announces 100% tariffs on pharmaceutical drugs, beginning October 1
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit
A Look at Pharma ETFs After Strong Q1 Earnings
Pharma ETFs in Focus Post Solid Q2 Earnings
A Look at Pharma ETFs Post Q1 Earnings
JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus
A Look at Pharma ETFs After Q4 Earnings
Pharma ETFs in Focus Post Q3 Earnings
Pharma ETFs in Focus Post Q2 Earnings
5 ETFs to Buy on JNJ's Q2 Earnings Strength
Biotech ETFs in Focus on Covid Vaccines' Fall Rollout
Pharma ETFs Gain Post Q1 Earnings
Can Health Care Stocks Outperform Again In 2023?
5 Best Sector ETFs of 2022
Amgen to Buy Horizon Therapeutics: ETFs to Bet On
2 Sector ETFs Hovering Around a 52-Week High
Pharma ETFs in Focus Post Q3 Earnings
Pharma ETFs in Focus Post Q1 Earnings
Pharma In Transition: Context And Opportunities
Solid Q4 Earnings Fail to Impress Pharma ETFs
Wave of Solid Q3 Earnings Push Pharma ETFs Higher
Pharma ETFs Gain on Q2 Earnings
Pharma ETFs in Focus Post Q1 Earnings
Biotech Innovations Remain At Forefront
Moving Beyond COVID In Biopharma
ETFs to Shine on Pfizer's Impressive COVID-19 Vaccine Update
Healthcare: A Wide Choice Of Large And Well-Established Companies
Pharma ETFs in Focus Post Q4 Earnings
ETFs to Shine as Pfizer's COVID-19 Vaccine Gets a Nod in Europe
The Reopening Killed The V-Shaped Recovery
Pharma ETFs Gain on Healthy Q4 Earnings
New Drug Pricing Reform